Effect of Sodium-Glucose Cotransporter 2 Inhibitors on the 24-Hour Ambulatory Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension: An Updated Meta-Analysis
Article in Endocrine Practice (March 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Who benefits from the blood pressure-lowering effects of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease? — Obese or non-obese?
Article in Hypertension Research (December 2023)
The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review
Article in Journal of Clinical Medicine (March 2023)